House approves Smith’s bill to reauthorize funding for umbilical cord blood stem cell research
The U.S. House of Representatives recently approved Rep. Chris Smith (NJ-04)’s legislation to authorize more than $280 million over five years for two collaborative programs that provide lifesaving treatments and therapies derived from ethically-sourced stem cell lines.
Learn More














